Try our Advanced Search for more refined results

Danco Laboratories, L.L.C., Petitioner v. Alliance for Hippocratic Medicine, et al.

  1. December 09, 2023

    Circuit-By-Circuit Guide To 2023's Most Memorable Moments

    A former BigLaw partner in his 30s made history by joining a preeminent circuit court, a former BigLaw partner in his 50s made waves by leaving the largest circuit, and a former chemist in her 90s made enemies by resisting a probe on the most specialized circuit. That's a small sample of the intrigue that flourished in 2023 throughout the federal appellate system, where diversity bloomed and controversy abounded.

  2. November 16, 2023

    Anti-Abortion Lawmakers Urge Justices To Skip Pill Ruling

    A strong showing for abortion rights on Election Day did not dissuade 109 GOP lawmakers from asking the U.S. Supreme Court to pass on reviewing a Fifth Circuit decision that would curb access to the abortion drug mifepristone.

  3. November 08, 2023

    Justices Told To Ignore Group's Take On Abortion Pill OK

    The federal government and a distributor of the abortion pill mifepristone urged the U.S. Supreme Court to reject an organization's argument over its challenge to the U.S. Food and Drug Administration's approval of the medication, saying that millions of women have used it to safely terminate pregnancies.

  4. October 17, 2023

    Abortion Foes Ask For Full Review Or Nothing In Drug Appeal

    Anti-abortion activists are telling the U.S. Supreme Court that if the justices review parts of a Fifth Circuit ruling reinstating the approval of an abortion medication, they should consider the entire case.

  5. October 13, 2023

    Supreme Court Deluged With Calls To Hear Abortion Pill Battle

    Politicians, doctors, legal professors and pharmaceutical companies have turned out en masse to urge the U.S. Supreme Court to review a Fifth Circuit panel's decision that would significantly curb access to the abortion medication mifepristone nationwide, attacking the ruling as deeply flawed and warning of its potentially seismic effects beyond abortion access.

  6. September 08, 2023

    Justices Urged To Hear Fight Over Abortion Pill Restrictions

    The U.S. Department of Justice and a distributor of the abortion medication mifepristone urged the U.S. Supreme Court on Friday to review a Fifth Circuit decision that threatens to curb access to the drug, marking the latest chapter in the national battle over abortion access following Roe v. Wade's reversal.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!